Biotech · Private company · Anaheim, CA, US
Biocorrx Pharmaceuticals Inc
Track this companyFree. Adds Biocorrx Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).Fiscal year 2025 · $3.3MNIH RePORTER 5U01DA059994-02 · fetched Nov 12, 2026
- Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).Fiscal year 2024 · $4.1MNIH RePORTER 1U01DA059994-01 · fetched Nov 12, 2026